Showing results (491-500 of 1,393) with videos related to

Sort By:
Pageof 140
JCO Precision Oncology|February 1, 2022
Knowledge-Guided Statistical Learning Methods for Analysis of High-Dimensional -Omics Data in Precision OncologyYize Zhao, Changgee Chang, Qi Long
JCO Precision Oncology|February 1, 2022
Outcomes in Patients With Pancreatic Adenocarcinoma With Genetic Mutations in DNA Damage Response Pathways: Results From the Know Your Tumor ProgramMichael J Pishvaian, Edik M Blais, Jonathan R Brody, et al.
JCO Precision Oncology|February 1, 2022
Plasma Cell-Free DNA Testing of Patients With EGFR Mutant Non-Small-Cell Lung Cancer: Droplet Digital PCR Versus Next-Generation Sequencing Compared With Tissue-Based ResultsChristi M J Steendam, Peggy Atmodimedjo, Evert de Jonge, et al.
JCO Precision Oncology|February 1, 2022
Circulating Tumor DNA Profiling of Advanced Biliary Tract CancersKabir Mody, Pashtoon M Kasi, JuDong Yang, et al.
JCO Precision Oncology|April 27, 2022
Distinct Neoadjuvant Chemotherapy Response and 5-Year Outcome in Patients With Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Tumors That Reclassify as Basal-Type by the 80-Gene SignaturePat W Whitworth, Peter D Beitsch, James V Pellicane, et al.
JCO Precision Oncology|April 20, 2022
Common Variant in ALDH2 Modifies the Risk of Breast Cancer Among Carriers of the p.K3326* Variant in BRCA2Wojciech Kluźniak, Agata Szymiczek, Amelie Rodrigue, et al.
JCO Precision Oncology|March 31, 2022
Hyperthermic Intraperitoneal Chemotherapy-Induced Molecular Changes in Humans Validate Preclinical Data in Ovarian CancerThanh H Dellinger, Ernest S Han, Mustafa Raoof, et al.
JCO Precision Oncology|May 28, 2019
Genetic Alterations Detected in Cell-Free DNA Are Associated With Enzalutamide and Abiraterone Resistance in Castration-Resistant Prostate CancerSamantha Torquato, Aparna Pallavajjala, Alexa Goldstein, et al.
JCO Precision Oncology|June 21, 2019
Prospective Comprehensive Genomic Profiling of Primary and Metastatic Prostate TumorsJon H Chung, Ninad Dewal, Ethan Sokol, et al.
JCO Precision Oncology|October 29, 2021
PARP Inhibition in Prostate Cancer With Homologous Recombination Repair AlterationsAlexander von Werdt, Laura Brandt, Orlando D Schärer, et al.
Pageof 140